rs267608324
Positions:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_ModerateBP6_ModerateBS2
The NM_004992.4(MECP2):c.-15C>T variant causes a 5 prime UTR change. The variant allele was found at a frequency of 0.0000275 in 1,199,391 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 10 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0000094 ( 0 hom., 0 hem., cov: 20)
Exomes 𝑓: 0.000029 ( 0 hom. 10 hem. )
Consequence
MECP2
NM_004992.4 5_prime_UTR
NM_004992.4 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 4.21
Genes affected
MECP2 (HGNC:6990): (methyl-CpG binding protein 2) DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of cognitive disability in females. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36).
BP6
Variant X-154092224-G-A is Benign according to our data. Variant chrX-154092224-G-A is described in ClinVar as [Benign]. Clinvar id is 143299.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Hemizygotes in GnomAdExome4 at 10 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MECP2 | NM_004992.4 | c.-15C>T | 5_prime_UTR_variant | 2/4 | ENST00000303391.11 | NP_004983.1 | ||
MECP2 | NM_001110792.2 | c.62+5380C>T | intron_variant | ENST00000453960.7 | NP_001104262.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MECP2 | ENST00000303391.11 | c.-15C>T | 5_prime_UTR_variant | 2/4 | 1 | NM_004992.4 | ENSP00000301948.6 | |||
MECP2 | ENST00000453960.7 | c.62+5380C>T | intron_variant | 1 | NM_001110792.2 | ENSP00000395535.2 |
Frequencies
GnomAD3 genomes AF: 0.00000942 AC: 1AN: 106155Hom.: 0 Cov.: 20 AF XY: 0.00 AC XY: 0AN XY: 28915
GnomAD3 genomes
AF:
AC:
1
AN:
106155
Hom.:
Cov.:
20
AF XY:
AC XY:
0
AN XY:
28915
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000164 AC: 3AN: 183111Hom.: 0 AF XY: 0.0000296 AC XY: 2AN XY: 67549
GnomAD3 exomes
AF:
AC:
3
AN:
183111
Hom.:
AF XY:
AC XY:
2
AN XY:
67549
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000293 AC: 32AN: 1093236Hom.: 0 Cov.: 30 AF XY: 0.0000279 AC XY: 10AN XY: 358726
GnomAD4 exome
AF:
AC:
32
AN:
1093236
Hom.:
Cov.:
30
AF XY:
AC XY:
10
AN XY:
358726
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000942 AC: 1AN: 106155Hom.: 0 Cov.: 20 AF XY: 0.00 AC XY: 0AN XY: 28915
GnomAD4 genome
AF:
AC:
1
AN:
106155
Hom.:
Cov.:
20
AF XY:
AC XY:
0
AN XY:
28915
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Rett syndrome Uncertain:1Benign:1
Benign, criteria provided, single submitter | curation | Centre for Population Genomics, CPG | Feb 18, 2024 | This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as benign. At least the following criteria are met: The allele frequency of this variant in at least one population in gnomAD is between 0.008% and 0.03% (BS1). The variant is observed in at least 2 individuals with no features of Rett Syndrome (BS2).PMID 10814719 , 10 hemizygous in gnomAD V4. Variant is found in an individual with an alternate molecular basis of disease (BP5). PMID: 10814719 - |
Uncertain significance, no assertion criteria provided | curation | RettBASE | Apr 10, 2002 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at